These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 34486491)
1. Mex-3 RNA binding MEX3A promotes the proliferation and migration of breast cancer cells via regulating RhoA/ROCK1/LIMK1 signaling pathway. Yan L; Li H; An W; Wei W; Zhang X; Wang L Bioengineered; 2021 Dec; 12(1):5850-5858. PubMed ID: 34486491 [TBL] [Abstract][Full Text] [Related]
2. B7-H3 promotes the migration and invasion of colorectal cancer cells via regulating the actin cytoskeleton and RhoA/ROCK1/LIMK1 signaling pathway. Zhao A; Zhu X; Wu H; Wang J; Zhang M; Xiang J; Xia S; Shi T; Xi Q Tissue Cell; 2024 Oct; 90():102518. PubMed ID: 39173456 [TBL] [Abstract][Full Text] [Related]
3. FHOD3 promotes carcinogenesis by regulating RhoA/ROCK1/LIMK1 signaling pathway in medulloblastoma. Yu J; Shi W; Zhao R; Shen W; Li H Clin Transl Oncol; 2020 Dec; 22(12):2312-2323. PubMed ID: 32447646 [TBL] [Abstract][Full Text] [Related]
4. The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4. Chen W; Hu L; Lu X; Wang X; Zhao C; Guo C; Li X; Ding Y; Zhao H; Tong D; Wang L; Huang C Breast Cancer Res Treat; 2023 Oct; 201(3):353-366. PubMed ID: 37433992 [TBL] [Abstract][Full Text] [Related]
5. DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion. Zhou Y; Su J; Shi L; Liao Q; Su Q Oncol Rep; 2013 Feb; 29(2):605-12. PubMed ID: 23233092 [TBL] [Abstract][Full Text] [Related]
6. MEX3A promotes colorectal cancer migration, invasion and EMT via regulating the Wnt/β-catenin signaling pathway. Xu J; Chen S; Hao T; Liu G; Zhang K; Zhang C; He Y J Cancer Res Clin Oncol; 2024 Jun; 150(6):319. PubMed ID: 38914858 [TBL] [Abstract][Full Text] [Related]
7. Rho-Associated Protein Kinase (ROCK) Promotes Proliferation and Migration of PC-3 and DU145 Prostate Cancer Cells by Targeting LIM Kinase 1 (LIMK1) and Matrix Metalloproteinase-2 (MMP-2). Gong H; Zhou L; Khelfat L; Qiu G; Wang Y; Mao K; Chen W Med Sci Monit; 2019 Apr; 25():3090-3099. PubMed ID: 31026254 [TBL] [Abstract][Full Text] [Related]
8. MYO3B promotes cancer progression in endometrial cancer by mediating the calcium ion-RhoA/ROCK1 signaling pathway. Zhang C; Zhang H; Yang X; Li S; Wang L; Su H; Yang J; Ding Y; Zhang X; Qiang B; Zhang S J Cancer Res Clin Oncol; 2024 Sep; 150(9):424. PubMed ID: 39297944 [TBL] [Abstract][Full Text] [Related]
9. MEX3A promotes triple negative breast cancer proliferation and migration via the PI3K/AKT signaling pathway. Jiang S; Meng L; Chen X; Liu H; Zhang J; Chen F; Zheng J; Liu H; Wang F; Hu J; Li Z Exp Cell Res; 2020 Oct; 395(2):112191. PubMed ID: 32738346 [TBL] [Abstract][Full Text] [Related]
10. Curcumin inhibits LPA-induced invasion by attenuating RhoA/ROCK/MMPs pathway in MCF7 breast cancer cells. Sun K; Duan X; Cai H; Liu X; Yang Y; Li M; Zhang X; Wang J Clin Exp Med; 2016 Feb; 16(1):37-47. PubMed ID: 25596714 [TBL] [Abstract][Full Text] [Related]
11. MEX3A promotes development and progression of breast cancer through regulation of PIK3CA. Shi X; Sun Y; Zhang Y; Wang W; Xu J; Guan Y; Ding Y; Yao Y Exp Cell Res; 2021 Jul; 404(1):112580. PubMed ID: 33811903 [TBL] [Abstract][Full Text] [Related]
12. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway. Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503 [TBL] [Abstract][Full Text] [Related]
13. NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction. Zhang C; Wang HJ; Bao QC; Wang L; Guo TK; Chen WL; Xu LL; Zhou HS; Bian JL; Yang YR; Sun HP; Xu XL; You QD Oncotarget; 2016 Nov; 7(45):73593-73606. PubMed ID: 27713154 [TBL] [Abstract][Full Text] [Related]
14. Mex3a promotes oncogenesis through the RAP1/MAPK signaling pathway in colorectal cancer and is inhibited by hsa-miR-6887-3p. Li H; Liang J; Wang J; Han J; Li S; Huang K; Liu C Cancer Commun (Lond); 2021 Jun; 41(6):472-491. PubMed ID: 33638620 [TBL] [Abstract][Full Text] [Related]
15. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-139-5p Suppresses Cell Malignant Behaviors in Breast Cancer through Targeting MEX3A. Chu J; Li T; Li L; Fan H Comput Math Methods Med; 2021; 2021():6591541. PubMed ID: 34765013 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis of Prognostic Value of MEX3A and Its Relationship with Immune Infiltrates in Ovarian Cancer. Zhang P; Su T; Zhang S J Immunol Res; 2021; 2021():5574176. PubMed ID: 34189143 [TBL] [Abstract][Full Text] [Related]
18. LIMK1 promotes the development of cervical cancer by up-regulating the ROS/Src-FAK/cofilin signaling pathway. Jia Y; Li Y; Du N; Zhao W; Liu Y Aging (Albany NY); 2024 Jul; 16(13):11090-11102. PubMed ID: 38975937 [TBL] [Abstract][Full Text] [Related]
19. ARHGEF10L contributes to liver tumorigenesis through RhoA-ROCK1 signaling and the epithelial-mesenchymal transition. Tang J; Liu C; Xu B; Wang D; Ma Z; Chang X Exp Cell Res; 2019 Jan; 374(1):46-68. PubMed ID: 30444969 [TBL] [Abstract][Full Text] [Related]
20. Effect of Cichoric Acid on Colorectal Cancer: Impact on Migration, Epithelial-Mesenchymal Transition, and Proliferation Ma S; Huang Z; Chen Q; Yin X Discov Med; 2024 Jan; 36(180):190-198. PubMed ID: 38273759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]